Immunovant (IMVT) PT Raised to $60 at Chardan Capital Markets
Tweet Send to a Friend
Chardan Capital Markets analyst Gbola Amusa raised the price target on Immunovant (NASDAQ: IMVT) to $60.00 (from $45.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
